EastPharma Ltd. announced revenue results for the nine months of 2013. For the period, the company's revenue in the nine months of 2013 was USD 164.1 million, down 3.9% from USD 170.8 million for the same period in 2012. The company's sales decrease was mainly driven by decreased volumes in DEVA's Veterinary business.
1st Jan change | Capi. | |
---|---|---|
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B | |
-2.27% | 4.81B |